BCS News

Gene-editing technology developer Feng Zhang awarded $500,000 Lemelson-MIT Prize

September 19, 2017

Gene-editing technology developer Feng Zhang awarded $500,000 Lemelson-MIT Prize

by 

Lemelson-MIT Program

Feng Zhang, a pioneer of the revolutionary CRISPR gene-editing technology, TAL effector proteins, and optogenics, is the recipient of the 2017 $500,000 Lemelson-MIT Prize, the largest cash prize for invention in the United States.

Tags: